Owner Investor / Financier Operator Developer
Celanese Corporation is a global chemicals and specialty materials company headquartered in Irving, Texas (NYSE: CE). The company operates two principal businesses: Acetyl Chain and Engineered Materials. Its Acetyl Chain portfolio includes acetic acid, vinyl acetate monomer (VAM), acetic anhydride, emulsions (including VAE), and redispersible polymer powders used in coatings, adhesives, construction, and industrial applications.
Through its Engineered Materials business, Celanese develops and produces engineering thermoplastics and elastomers—such as POM, PBT, PA, TPE, and ultra-high molecular weight polyethylene (UHMW-PE)—for applications in automotive, electrical and electronics, consumer goods, medical, and industrial markets. The company maintains a global manufacturing and compounding network across the Americas, Europe, and Asia, with major production hubs including facilities in China and Germany.
chemXplore tracks 9 projects involving Celanese, of which 2 are active.
Besides these 2, the record holds 7 completed projects.
Closest to start-up first.
The 7 that are completed, on hold or cancelled are in the record. See all 9 in chemXplore →
Transaction yields roughly $152 million cash; seller retains 11% and will operate a diketene unit in transition; expected close in Q4.
Deal targets >30% weight reduction vs steel for humanoid robot joints, with materials supply, technical support and mass-production validation.
Adjusted EPS $2.45; net sales $2.8bn; adjusted EBIT $470m and operating EBITDA $649m. Q3 EPS guide $1.35–$1.75; full-year adjusted EPS ~$6.00 and FCF $700–$800m.
Amsterdam court dismissed Shell's damages claim and Repsol's declaratory-liability claim tied to a 2020 EC ethylene settlement.
Starts July 6, succeeding retiring CFO Vince Morales after 41 years; will report to CEO Tim Knavish, lead corporate development and IT, bringing 25+ years of financial leadership.
Operations in Mechelen to cease by September 2024, incurring $60-75M in costs. Employee termination costs pending consultation. Facility produces engineering thermoplastics and elastomers.
The expansion will add 34KT annual capacity by 2024, supporting EV market growth and medical grade production. Site selection is ongoing, considering both existing and new locations.
Celanese is investing in new reactors and debottlenecking projects to boost vinyl acetate ethylene emulsions and redispersible polymer powders capacities in Europe and Asia by 2023.
active all projects
What each is building and closing, and the pipelines and grids between them, on one map.
